Dolastatin 10 in Treating Patients With Recurrent or Metastatic Soft Tissue Sarcoma

Summary

Phase II trial to study the effectiveness of dolastatin 10 in treating patients who have recurrent or metastatic soft tissue sarcoma. Drugs used in chemotherapy use different ways to stop tumor cells from dividing so they stop growing or die.

Timeline

Start

1999-04

Primary completion

2000-07

Completion

—

Drugs

Indications